Remendium Therapeutics entered the industry of Biological Products Manufacturers in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 325414, which describes it as a Biological Products Manufacturers. For further clarification, the SIC classifies this business under the code 2836 and described it as a Biological Products Manufacturers. The business provides service to the B2B market.
To acquire more information, please contact Alan Moy by calling (319) 887-2873 during business hours. You can also write to the business’ Single Location at 540 East Jefferson St, Iowa City, Iowa IA 52245. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Remendium Therapeutics |
| Representative: | Alan Moy |
| Place of Business: | 540 East Jefferson St, Iowa City, IA 52245 |
| Contact Number: | (319) 887-2873 |
| Type of Service: | Biological Products Manufacturers |
| SIC Number: | 2836 |
| NAICS Number: | 325414 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2013 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Remendium Therapeutics is a company operating from Johnson, Iowa providing professional Biological Products Manufacturers and relevant B2B variables. It was founded in 2013 and registered with the SIC code 2836 as Biological Products Manufacturers, and with the NAICS code 325414 as Biological Products Manufacturers.
With a current employee count of 1 to 4, Remendium Therapeutics has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Alan Moy at (319) 887-2873 for related queries, or to locate its Single Location using the coordinates 41.662587,-91.527945.
The Single Location can also be found at the street address 540 East Jefferson St in Iowa City, Iowa 52245 and can be engaged online through the company website at , the company Twitter , and Facebook page .